Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors

30 Aug 2018

Abstract excerpt

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused mainly by lack of dopamine in the brain. Dopamine is a neurotransmitter involved in movement, motivation, memory, and other functions; its level is decreased in PD brain as a result of dopaminergic cell death. Dopamine loss in PD brain is a cause of motor deficiency and, possibly, a reason of the cognitive deficit observed in some PD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30214392
DOI: 10.3389/fnins.2018.00612

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Parkinson’s Disease: Biomarkers, Treatment, and Risk FactorsPMID 30214392Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related DiseasesSemantic proximity Read ↗

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.Semantic proximity Read ↗

Parkinson’s Disease: From Gene–Environment Risk to Precision TherapySemantic proximity Read ↗

Parkinson's disease: etiopathogenesis and treatment.Semantic proximity Read ↗

Parkinson's disease.Semantic proximity Read ↗

Parkinson DiseaseSemantic proximity Read ↗

Parkinson's Disease: From Gene-Environment Risk to Precision Therapy.Semantic proximity Read ↗

Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive ReviewSemantic proximity Read ↗

Biomarker Research in Parkinson’s Disease Using Metabolite ProfilingSemantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

[Epidemiology and causes of Parkinson's disease].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.